TRIANA BIOMEDICINES, INC.
Profile
Company Names
TRIANA BIOMEDICINES, INC.
SANTI THERAPEUTICS, INC.
Addresses
1050 WALTHAM STREET, SUITE 301, LEXINGTON, MA 02421
400 TOTTEN POND ROAD, SUITE 120, WALTHAM, MA 02451
400 TOTTEN POND ROAD, SUITE 110, WALTHAM, MA 02451
200 BERKELEY STREET, 18TH FLOOR, C/O RA CAPITAL, BOSTON, MA 02116
Phone Numbers
781-317-4414
617-778-2572
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS
Year Incorporated:
2019
State Incorporated:
DELAWARE
Total Amount Raised:
$178,611,967.00
Number of Funding Rounds:
4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2025-11-26
$120,061,960.00
$120,061,960.00
$0.00
Equity
3
2022-01-28
$42,550,007.00
$85,100,014.00
$42,550,007.00
Equity
2
2021-09-03
$10,000,000.00
$10,000,000.00
$0.00
Equity
1
2020-05-22
$6,000,000.00
$14,000,000.00
$8,000,000.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
SHELLEY
CHU
DIRECTOR
KALIDEX PHARMACEUTICALS, INC.
| ABINGWORTH BIOVENTURES VII LP
| VENATORX PHARMACEUTICALS, INC.
| IFM QUATTRO, INC.
| IFM CINQUE, INC.
| IFM CONTINUA, INC.
| SCORPION THERAPEUTICS, INC.
| ENLAZA THERAPEUTICS, INC.
| ABATA THERAPEUTICS, INC.
| PROTEGO BIOPHARMA
| TRIANA BIOMEDICINES, INC.
| SEISMIC THERAPEUTIC, INC.
| ANTARES THERAPEUTICS, INC.
| PROTEGO BIOPHARMA, INC.
| ODYSSEY THERAPEUTICS, INC.
MILIND
DESHPANDE
DIRECTOR, EXECUTIVE OFFICER
DAVID
GRAYZEL
DIRECTOR
ANNOVATION BIOPHARMA, INC.
| ARTEAUS THERAPEUTICS, LLC
| ATLAS VENTURE FUND XI, L.P.
| AKRIVEIA THERAPEUTICS, LLC
| ATLAS VENTURE OPPORTUNITY FUND I, L.P.
| AFFINIA THERAPEUTICS INC.
| ATLAS VENTURE FUND XII, L.P.
| AEROVATE THERAPEUTICS, INC.
| XILIO THERAPEUTICS, INC.
| SANTI THERAPEUTICS, INC.
| ATLAS VENTURE OPPORTUNITY FUND II, L.P.
| TRIANA BIOMEDICINES, INC.
| ATLAS VENTURE FUND XIII, L.P.
| COMANCHE BIOPHARMA CORP.
| ATLAS VENTURE FUND XIV, L.P.
ANDREW
HEDIN
DIRECTOR
LORENCE
KIM
DIRECTOR
SERES HEALTH, INC.
| MODERNA LLC
| MODERNA THERAPEUTICS, INC.
| ABATA THERAPEUTICS, INC.
| ADARX PHARMACEUTICALS, INC.
| ASCENTA CAPITAL SPV I, L.P.
| ASCENTA CAPITAL PROJECT TURING SPV, L.P.
| ODYSSEY THERAPEUTICS, INC.
| ASCENTA CAPITAL PROJECT ARGOS SPV, L.P.
| ASCENTA CAPITAL FUND I, L.P.
| ASCENTA CAPITAL PROJECT IKIGAI SPV, L.P.
| ASCENTA CAPITAL PROJECT HENRI SPV, L.P.
| TRIANA BIOMEDICINES, INC.
ANDREW
LEVIN
DIRECTOR
IMMUNETICS, INC.
| ARVINAS HOLDING COMPANY, LLC
| SYNTHORX, INC.
| CLEANBREAK, INC.
| CLEAR CREEK BIO, INC.
| IMBRIA PHARMACEUTICALS, INC.
| ELIEM THERAPEUTICS, INC.
| ATHENEN THERAPEUTICS, INC.
| ARCUATE THERAPEUTICS, INC.
| AEROVATE THERAPEUTICS, INC.
| SANTI THERAPEUTICS, INC.
| CYTEK BIOSCIENCES, INC.
| METAGENOMI TECHNOLOGIES, LLC
| LUSARIS THERAPEUTICS, INC.
| SUPERLUMINAL MEDICINES, INC.
| NAVIGATOR MEDICINES, INC.
| AKTIS ONCOLOGY, INC.
| PAHR THERAPEUTICS, INC.
| LONESTAR MEDICINES, INC.
| SOLSTICE ONCOLOGY, INC.
| SLATE MEDICINES, INC.
| CLIMB BIO, INC.
CHRISTOPHER
O-DONNELL
DIRECTOR
JOSHUA
RESNICK
DIRECTOR
JERICHO CAPITAL PARTNERS, L.P.
| COAXIA INC
| JERICHO CAPITAL INTERNATIONAL LTD.
| LIVESTREAM, LLC
| JERICHO CAPITAL PARTNERS L.P.
| SUGARFINA, LLC
| RANA THERAPEUTICS, LLC
| MIRAGEN THERAPEUTICS, INC.
| JERICHO CAPITAL SPECIAL OPPORTUNITIES LTD
| AVROBIO, INC.
| SUGARFINA, INC.
| RIBOMETRIX, INC.
| NAYAN THERAPEUTICS, INC.
| JERICHO ASIA OPPORTUNITIES LTD.
| ATHENEN THERAPEUTICS, INC.
| ARCUATE THERAPEUTICS, INC.
| AEROVATE THERAPEUTICS, INC.
| SANTI THERAPEUTICS, INC.
| VOR BIOPHARMA INC.
| AVILAR THERAPEUTICS, INC.
| PEPGEN INC.
| TRIANA BIOMEDICINES, INC.
| ALIADA THERAPEUTICS, INC.
| OPENSKY VENTURES FUND I, LP
PATRICK
TROJER
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
